The U.S. Food and Drug Administration (FDA) has published an outline of its research priorities regarding the dairy food safety implications of
Highly Pathogenic Avian Influenza (HPAI) H5N1.
With a focus on fresh-cut produce in the U.S./North America, this article explores critical questions related to the improvement and modernization of the microbial outbreak investigation process.
The Maine Center for Disease Control and Prevention (Maine CDC) has expanded fish consumption advisories based on the results of ongoing testing for per- and polyfluroalkyl substances (PFAS) in bodies of water across the state.
Following a lead poisoning outbreak linked to adulterated cinnamon fruit puree pouches that affected hundreds of children, the U.S. Food and Drug Administration (FDA) issued a warning letter to Dollar Tree, Inc. due to its failure to remove the recalled products from stores.
The National Association of Wine Retailers (NAWR) has published a paper that provides a comprehensive overview of U.S. regulation of alcohol sales, the challenges within the current system, and possibly beneficial regulatory changes.
The EU Heads of Food Safety Agencies (HoA) recently published a list of 117 substances that should be prohibited or restricted in food supplements to protect public health.
The U.S. Food and Drug Administration (FDA) has issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Final Rule, fulfilling Subpart 204 of the Food Safety Modernization Act (FSMA 204).
The European Commission is taking strides to improve honey authenticity, including setting new origin labeling requirements, and the development of harmonized traceability requirements and improved methods of composition analysis and origin tracing. The Commission is assembling a group of experts called the “Honey Platform” to advise this work and is accepting applications.
So far, 12 severe cases of illness, including seizures, have been linked to the consumption of Diamond Shruumz brand mushroom-based chocolates and candies. The products are marketed as way to “microdose” (implying a drug-like effect), but also claim not to contain psychedelic substances.
The infant formula shortage of 2022 was precipitated by FDA’s delayed response to whistleblower complaints about contaminated product—a delay caused by the agency not having the necessary policies and procedures in place to address the issue at the time—according to a new report published by the U.S. DHHS’ Office of the Inspector General.
RSS
